Sai Parenteral's

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
586.70
17.75 (3.12%)
BSENSE

Aug 10

BSE+NSE Vol: 2.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039988,
    "name": "Sai Parenteral's",
    "stock_name": "Sai Parenteral's",
    "full_name": "Sai Parenterals Ltd",
    "name_url": "stocks-analysis/sai-parenteral-s",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "586.70",
    "chg": 17.75,
    "chgp": "3.12%",
    "dir": 1,
    "prev_price": "568.95",
    "mcapval": "2,569.00 Cr",
    "mcap": "",
    "scripcode": 544742,
    "symbol": "SAIPARENT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0H9F01037",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "2.81 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sai-parenteral-s-10039988-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Sai Parenterals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-sai-parenterals-ltd-4001868",
        "imagepath": "",
        "date": "2026-05-20 23:20:18",
        "description": "Sai Parenterals Ltd is scheduled to declare its results on 23 May 2026...."
      }
    ],
    "total": 1,
    "sid": "10039988",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sai-parenterals-10039988"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "07-Aug-2026",
      "details": "The Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August 2026.",
      "datetime": "04-Aug-2026",
      "details": "Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026. 3. Any other business with the permission of the Chair.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "18-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

07-Aug-2026 | Source : BSE

The Q1 earnings conference call for the FY 2026-27 is scheduled to be held on 12th August 2026.

Board Meeting Intimation for Meeting Proposed To Be Held On 11Th August 2026.

04-Aug-2026 | Source : BSE

Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026. 3. Any other business with the permission of the Chair.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

18-Jul-2026 | Source : BSE

Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

(11 Aug 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available